Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

KRYS US Equity

Krystal Biotech, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1711279 · FY ends Dec 31
$343.34
+10.52 (+3.16%)
USD · as of 2026-08-19 · marketstack
10 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-038-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-218-K 8.01Other eventssec.gov ↗
2026-05-208-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-0413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Krishnan Krish Ssec.gov ↗
2026-05-048-K 9.01Financial statements and exhibitssec.gov ↗
2026-04-2913GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD PORTFOLIO MANAGEMENT LLCsec.gov ↗
2026-03-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-02-178-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-01-128-K 7.01Regulation FD disclosuresec.gov ↗
2026-01-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-01-088-K 7.01Regulation FD disclosuresec.gov ↗
2025-12-238-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2025-11-038-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-228-K 8.01Other eventssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-10-22

Every row is a filed document, checked against its EDGAR index.